Zerwes; Hans-Gunter
Patent Applications and Registrations
Patent applications and USPTO patent grants for Zerwes; Hans-Gunter.The latest application filed is for "use of rapamycin derivatives in vasculopathies and xenotransplantation".
- Zerwes; Hans-Gunter - Lorrach DE
| Patent | Date |
|---|---|
| Use Of Rapamycin Derivatives In Vasculopathies And Xenotransplantation App 20140187574 - Schuler; Walter ; et al. | 2014-07-03 |
| Use Of Rapamycin Derivatives In Vasculopathies And Xenotransplantation App 20120177690 - Schuler; Walter ; et al. | 2012-07-12 |
| Use Of Rapamycin Derivatives In Chronic Rejection App 20100152105 - Schuler; Walter ; et al. | 2010-06-17 |
| Isothiourea derivatives of imadazo[2,1-b]Thiazoles and 5,6-dihydro derivatives thereof useful as CXCR4 chemokine receptor inhibitors Grant 7,671,078 - Glickman , et al. March 2, 2 | 2010-03-02 |
| Ergoline derivatives Grant 7,666,877 - Baenteli , et al. February 23, 2 | 2010-02-23 |
| Pyrimidine Derivatives App 20100010025 - Duthaler; Rudolf ; et al. | 2010-01-14 |
| Ergoline Derivatives App 20090018127 - Baenteli; Rolf ; et al. | 2009-01-15 |
| Piperdine Derivatives as CCR5 Inhibitors App 20080249111 - ALBERT; Rainer ; et al. | 2008-10-09 |
| Cxcr4 Binding Molecules App 20080234294 - Kovarik; Jiri ; et al. | 2008-09-25 |
| Piperidine derivatives as CCR5 inhibitors Grant 7,399,771 - Albert , et al. July 15, 2 | 2008-07-15 |
| Isothiourea derivatives App 20070161618 - Glickman; Fraser ; et al. | 2007-07-12 |
| Piperidine derivatives as ccr5 inhibitors App 20060004047 - Albert; Rainer ; et al. | 2006-01-05 |
| Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors App 20040142920 - Albert, Rainer ; et al. | 2004-07-22 |
| Transgenic animals for studying regulation of genes App 20040016012 - Kaslin, Edgar ; et al. | 2004-01-22 |
| Transgenic animals for studying regulation of genes Grant 6,632,978 - Kaslin , et al. October 14, 2 | 2003-10-14 |
| Use of rapamycin derivatives in vasculop atheis and xenotransplantation App 20020127248 - Schuler, Walter ; et al. | 2002-09-12 |
| Use of 40-O-(2-hydroxy)ethylrapamycin for treatment of restenosis and other disorders Grant 6,384,046 - Schuler , et al. May 7, 2 | 2002-05-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 